Literature DB >> 31227585

Effects of Exercise in Addition to a Family-Based Lifestyle Intervention Program on Hepatic Fat in Children With Overweight.

Idoia Labayen1, María Medrano2, Lide Arenaza2, Edurne Maíz3, Maddi Osés2, Vicente Martínez-Vizcaíno4,5, Jonatan R Ruiz6, Francisco B Ortega6.   

Abstract

OBJECTIVE: Pediatric hepatic steatosis is highly prevalent and closely related to type 2 diabetes. This study aimed to determine whether the addition of supervised exercise to a family-based lifestyle and psycho-educational intervention results in greater reduction of percentage of hepatic fat (HF), adiposity, and cardiometabolic risk factors in children with overweight/obesity. RESEARCH DESIGN AND METHODS: The study subjects of this nonrandomized, two-arm, parallel design clinical trial were 116 overweight/obese children (10.6 ± 1.1 years of age, 53.4% girls) living in Vitoria-Gasteiz (Spain). For 22 weeks, they followed either a lifestyle and psycho-education program (control intervention [CInt], N = 57), consisting of two family-based education sessions/month, or the same plus supervised exercise (intensive intervention [II], N = 59) focused mainly on high-intensity aerobic workouts (3 sessions/week, 90 min/session). The primary outcome was the change in percentage of HF (as measured by MRI) between baseline and the end of the intervention period. Secondary outcomes included changes in BMI, fat mass index (FMI), abdominal fat (measured by DEXA), blood pressure, triglycerides, HDL, LDL, γ-glutamyl transferase, glucose, and insulin concentrations.
RESULTS: A total of 102 children completed the trial (N = 53 and N = 49 in the CInt and II groups, respectively). Percentage of HF decreased only in the II group (-1.20 ± 0.31% vs. 0.04 ± 0.30%, II and CInt groups, respectively), regardless of baseline value and any change in adiposity (P < 0.01). BMI, FMI, abdominal fat (P ≤ 0.001), and insulin (P < 0.05) were reduced in both groups.
CONCLUSIONS: Multicomponent intervention programs that include exercise training may help to reduce adiposity, insulin resistance, and hepatic steatosis in overweight/obese children.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2019        PMID: 31227585     DOI: 10.2337/dc19-0351

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  The Effect of a Family-Based Lifestyle Education Program on Dietary Habits, Hepatic Fat and Adiposity Markers in 8-12-Year-Old Children with Overweight/Obesity.

Authors:  Lide Arenaza; María Medrano; Maddi Oses; Maria Amasene; Ignacio Díez; Beatriz Rodríguez-Vigil; Idoia Labayen
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

2.  Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity.

Authors:  Maddi Oses; Cristina Cadenas-Sanchez; María Medrano; Arkaitz Galbete; Emiliano Miranda-Ferrua; Jonatan R Ruiz; Felix Sánchez-Valverde; Francisco B Ortega; Rafael Cabeza; Arantxa Villanueva; Fernando Idoate; Idoia Labayen
Journal:  Pediatr Obes       Date:  2022-04-08       Impact factor: 3.910

3.  Fat-free/lean body mass in children with insulin resistance or metabolic syndrome: a systematic review and meta-analysis.

Authors:  Diana Paola Córdoba-Rodríguez; Iris Iglesia; Alejandro Gomez-Bruton; Gerardo Rodríguez; José Antonio Casajús; Hernan Morales-Devia; Luis A Moreno
Journal:  BMC Pediatr       Date:  2022-01-22       Impact factor: 2.125

4.  Additive Effects of Exercise or Nutrition Intervention in a 24-Month Multidisciplinary Treatment with a Booster Intervention for Children and Adolescents with Overweight or Obesity: The ICAAN Study.

Authors:  Sarah Woo; Young-Su Ju; Young-Gyun Seo; Yoon-Myung Kim; Hyunjung Lim; Kyung-Hee Park
Journal:  Nutrients       Date:  2022-01-17       Impact factor: 5.717

5.  Supervised Exercise Immediately After Bariatric Surgery: the Study Protocol of the EFIBAR Randomized Controlled Trial.

Authors:  Enrique G Artero; Manuel Ferrez-Márquez; María José Torrente-Sánchez; Elena Martínez-Rosales; Alejandro Carretero-Ruiz; Alba Hernández-Martínez; Laura López-Sánchez; Alba Esteban-Simón; Andrea Romero Del Rey; Manuel Alcaraz-Ibáñez; Manuel A Rodríguez-Pérez; Emilio Villa-González; Yaira Barranco-Ruiz; Sonia Martínez-Forte; Carlos Castillo; Carlos Gómez Navarro; Jesús Aceituno Cubero; Raúl Reyes Parrilla; José A Aparicio Gómez; Pedro Femia; Ana M Fernández-Alonso; Alberto Soriano-Maldonado
Journal:  Obes Surg       Date:  2021-07-15       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.